Showing results (31-40 of 156) with videos related to
Sort By:
Pageof 16
Cell Cycle (Georgetown, Tex.)|February 18, 2009
Systemic siRNA delivery to leukocyte-implicated diseasesDan Peer, Motomu ShimaokaCurrent Opinion in Biotechnology|January 17, 2016
RNA nanomedicines: the next generation drugs?Manu Smriti Singh, Dan PeerJournal of Controlled Release : Official Journal of the Controlled Release Society|January 11, 2012
Altering the immune response with lipid-based nanoparticlesDalit Landesman-Milo, Dan PeerDrug Delivery and Translational Research|March 20, 2015
Toxicity profiling of several common RNAi-based nanomedicines: a comparative studyDalit Landesman-Milo, Dan PeerBioconjugate Chemistry|January 7, 2016
Transforming Nanomedicines From Lab Scale Production to Novel Clinical ModalityDalit Landesman-Milo, Dan PeerCell Reports. Medicine|January 7, 2025
Delivery of genetic medicines for muscular dystrophiesYulia Chulanova, Dor Breier, Dan PeerNanomedicine (London, England)|November 30, 2011
Grand challenges in modulating the immune response with RNAi nanomedicinesMeir Goldsmith, Shoshy Mizrahy, Dan PeerAdvanced Drug Delivery Reviews|April 17, 2020
Targeted lipid nanoparticles for RNA therapeutics and immunomodulation in leukocytesNuphar Veiga, Yael Diesendruck, Dan PeerACS Nano|March 26, 2014
Precision nanomedicine in neurodegenerative diseasesMeir Goldsmith, Lilach Abramovitz, Dan PeerBiochimica Et Biophysica Acta|May 6, 2003
Hyaluronan is a key component in cryoprotection and formulation of targeted unilamellar liposomesDan Peer, Anat Florentin, Rimona MargalitPageof 16